Cargando…

Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics

In the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy. This has led to many new advance and insights in the understanding of pathobiology of malignant hematology. New knowledge of disease molecular...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Tao, Jianguo (Editor ), Sotomayor, Eduardo (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Dordrecht : Springer Netherlands : Imprint: Springer, 2012.
Edición:1st ed. 2012.
Colección:Cancer Growth and Progression ; 14
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-94-007-5028-9
003 DE-He213
005 20220118114012.0
007 cr nn 008mamaa
008 121116s2012 ne | s |||| 0|eng d
020 |a 9789400750289  |9 978-94-007-5028-9 
024 7 |a 10.1007/978-94-007-5028-9  |2 doi 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 571.978  |2 23 
082 0 4 |a 616.994  |2 23 
245 1 0 |a Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics  |h [electronic resource] /  |c edited by Jianguo Tao, Eduardo Sotomayor. 
250 |a 1st ed. 2012. 
264 1 |a Dordrecht :  |b Springer Netherlands :  |b Imprint: Springer,  |c 2012. 
300 |a VI, 426 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Cancer Growth and Progression ;  |v 14 
520 |a In the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy. This has led to many new advance and insights in the understanding of pathobiology of malignant hematology. New knowledge of disease molecular pathology, cytogenetic, epigenetic and genomic alterations have provided new strategies to attack and eradicate tumor cells at molecular level and significantly impacted our current therapeutics for hematological malignancies. The recent and ongoing rapid expansion of knowledge in this area has become extensive, dynamic and diffuse over the literature and research publications. This has led to the need to capture and compile the new and current information about hematologic cancer with special emphasis on translation from molecular pathobiology to targeted therapeutics. In this book experts from around the world share their thoughts and knowledge about the pathobiology of hematologic cancer, as well as their view on current treatment approaches and future development in these malignant hematologic diseases. This book is well suited for hematology residents, fellows and hematology-oncology physicians, hematopathologist as well as basic research scientist in the area of hematologic malignancies. . 
650 0 |a Cancer. 
650 0 |a Hematology. 
650 0 |a Medicine-Research. 
650 0 |a Biology-Research. 
650 0 |a Cell death. 
650 0 |a Cytology. 
650 1 4 |a Cancer Biology. 
650 2 4 |a Hematology. 
650 2 4 |a Biomedical Research. 
650 2 4 |a Cell Death. 
650 2 4 |a Cell Biology. 
700 1 |a Tao, Jianguo.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Sotomayor, Eduardo.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9789400750296 
776 0 8 |i Printed edition:  |z 9789400795815 
776 0 8 |i Printed edition:  |z 9789400750272 
830 0 |a Cancer Growth and Progression ;  |v 14 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-94-007-5028-9  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)